Skip to main content
OpenTrials
Completed

NCT Number: NCT06930898

Improving Breast Health Knowledge Among Women Using a Gamified Metaverse-Based Platform

This randomized controlled trial aimed to evaluate the effectiveness of Mammoverse, a gamified metaverse-based educational platform, in improving breast health knowledge among women in China. Participants were randomly assigned to either a gamified or non-gamified version of the platform. Both groups received identical educational content, but only the gamified group experienced interactive game elements such as avatars, progress feedback, and rewards. Knowledge was assessed at baseline, immediately post-intervention, and at 4-week follow-up. The study found that the gamified platform significantly improved knowledge retention and participant engagement compared to the non-gamified version.

This ClinicalTrials.gov registration reflects only the randomized controlled trial (RCT) portion of a broader mixed-methods study that was approved by the University of Malaya Research Ethics Committee (Ref: UM.TNC2/UMREC_3967). The full study protocol includes three methodological approaches, and this registration pertains specifically to the RCT component involving the Mammoverse platform. Other study components are not included in this registration.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Health Education Adherence Interventions Behavior Breast Diseases Breast Neoplasms Health Behavior Medication Adherence Neoplasms Neoplasms by Site Patient Acceptance of Health Care Patient Compliance Skin Diseases Skin and Connective Tissue Diseases Treatment Adherence and Compliance

Age range

18 year–65 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Online Recruitment - Hangzhou, Zhejiang, China, Hangzhou, Zhejiang, China

Loading trial locations.

About this study

Mammoverse is a 3D metaverse environment designed to promote breast health knowledge through immersive and interactive learning. The gamified version included user avatars, badges, tasks, and personalized feedback to increase motivation and engagement. The study recruited 72 women aged 18 and above, and used a pre-post-follow-up design. Outcome measures were based on an adapted 18-item Breast Health Literacy Questionnaire. The trial was conducted entirely online, with ethics approval from the University of Malaya Research Ethics Committee.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female participants aged 18 years and above
  • Able to read and understand Chinese
  • Access to a digital device and stable internet connection
  • Willing to provide informed consent

Exclusion criteria

  • Cognitive impairment or mental health condition that affects participation
  • Inability to complete the full intervention and follow-up sessions
  • Incomplete baseline assessment

Treatment and study plan

Gamified Mammoverse Platform

Behavioral

A gamified, metaverse-based platform delivering breast health education through story-based tasks, interactive challenges, points, rewards, badges, and virtual incentives.

Standard Mammoverse Platform

Behavioral

A non-gamified version of the Mammoverse platform that provides the same breast health educational content.

Primary outcomes

  1. Change in Breast Health Knowledge Score from Baseline to 4 Weeks Post-Intervention

    Time frame: Baseline and 4 weeks post-intervention

    Assessed using an 18-item adapted Breast Health Literacy Questionnaire. Scores range from 0 to 18, with higher scores indicating greater knowledge. Main comparison is between baseline and 4-week follow-up.

Secondary outcomes

  1. Change in Breast Health Knowledge Score from Baseline to Immediately Post-Intervention

    Time frame: Baseline and immediately post-intervention

    Same questionnaire used to assess immediate knowledge gain after the intervention.

Other outcomes

  1. Knowledge Retention from Immediately Post-Intervention to 4 Weeks Post

    Time frame: Immediately post-intervention and 4 weeks post-intervention

    Change in knowledge scores to evaluate retention over 4 weeks.

Sponsors and collaborators

Lead sponsor

University of Malaya

Other

Registry information

Official study title

Improving Breast Health Knowledge Among Women Using a Gamified Metaverse-Based Platform: A Randomized Controlled Trial

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Apr 16, 2025
Registry last updated
Apr 18, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.